Panel Discussion: Exploring the Weight Independent Benefits of GLP-1

Time: 3:00 pm
day: Conference Day One


  • Evaluating the impact of GLP-1s: are all observed benefits attributable to weight reduction or are other mechanisms in play?
  • Considering how co-morbidities should be addressed from a clinical and commercial strategy perspective
  • Clarifying uncertainties related to expanding into numerous new therapeutic areas